不同亚型急性脑梗死出血转化的发生及相关危险因素分析

中国临床解剖学杂志 ›› 2013, Vol. 31 ›› Issue (4): 480-483.

不同亚型急性脑梗死出血转化的发生及相关危险因素分析

郭文超^1,2，　潘速跃¹

1.南方医科大学南方医院神经内科，广州 510515； 2.中山市人民医院，广东中山 528400

收稿日期:2013-01-15 发布日期:2013-07-24
通讯作者: 潘速跃，教授，E-mail：Pansuyue82@yahoo.com.cn E-mail:jurgenwen@sina.com
作者简介:郭文超（1967-），男，神经病学硕士，在职博士研究生，副主任医师,研究方向：脑血管病
基金资助:
中山市科技局科技创新基金资助（20102C025）

The prevalence and related risk factors of hemorrhagic transformation in different subtype of cerebral infarction

GUO Wen-chao ^1.2, PAN Su-yue¹

1.Department of Neurology, Nanfang Hospital，Southern Medical University, Guangzhou 510515, China; 2. Zhongshan City People's Hospital, Zhongshan 528403

Received:2013-01-15 Published:2013-07-24

摘要/Abstract

摘要：

目的　研究不同亚型急性脑梗死出血转化的发生率及相关危险因素。方法　选择南方医科大学南方医院及中山市人民医院神经内科自2008年1月至2011年12月收治的连续入院的急性脑梗死患者977例，按是否发生出血转化分为出血转化组（HT）142例及非出血转化组（NHT）835例，登记所有患者的基线资料并统计各病例的TOAST分型，分析不同亚型的急性脑梗死患者出血转化的发生率，采用Logistic回归分析脑出血转化的危险因素。结果　大动脉粥样硬化性、心源性脑梗死、小动脉闭塞型脑梗死出血转化的发生率分别为12.8%、31.1%、6.6%；多因素Logistic回归分析显示出血转化的主要危险因素分别为大面积脑梗死（OR=10.498,95% CI6.520～17.131,P=0.000）、心房纤颤（OR=1.718,95% CI 　1.217～2.941,P=0.005）、糖尿病（OR=1.817,95%CI 1.135～2.903,P=0.012）及抗凝（OR=7.748,95% CI 　2.416～25.847,P=0.000）治疗。高血压、高低密度脂蛋白胆固醇以及抗血小板聚集治疗不是HT的独立危险因素。结论　不同亚型脑梗死HT发生率不同，心源性脑梗死是脑出血转化的主要原因，大面积脑梗死、心房纤颤、糖尿病及抗凝治疗是HT的独立危险因素。

关键词: 脑梗死, 出血转化, 危险因素

Abstract:

Objective　To analyze the prevalence and related risk factors of hemorrhagic transformation (HT) in patients with different subtype of acute cerebral infarction. Methods The Clinical data of 977 patients with cerebral infarction were analyzed retrospectively. They were divided into HT group ( n=142) and non-HT group ( n=835) according to whether they had HT or not．TOAST classification in both groups was observed. The risk factors for HT were identified by univariate chi-square test and multivariate logistic regression analysis, and the incidences of HT in various types of cerebral infarction in the TOAST classification were compared． Results The results of multivariate logistic regression analysis showed that massive cerebral infarction (OR=10.498,95%CI 6.520～17.131,P=0.000), atrial fibrillation(OR=1.718, 95%CI 1.217～2.941, P=0.005), anticoagulation (OR=7.748, 95%CI 2.416～25.847, P=0.000), and diabetes (OR=1.817, 95%CI 1.135～2.903, P=0.012) were the independent risk factors for HT. Hypertension, high cholesterol, and the history of anti-platelet aggregation were not the independent risk factors for HT. In the TOAST classification, the HT incidence in patients with cardio embolic cerebral infarction was the highest (31.1%, 88/283), the HT incidence of small artery occlusion was lower (6.6%, 17/257), and the HT incidence of large artery atherosclerosis was (12.8%, 24/187). Conclusion Massive cerebral infarction, atrial fibrillation, anticoagulation, diabetes are the independent risk factors for HT. Cardioembolic cerebral infarction is one of the major reasons for the occurrence of HT．

Key words: Brain infarction, Risk factors, Hemorrhagic transformation

中图分类号:

R743

郭文超, 潘速跃. 不同亚型急性脑梗死出血转化的发生及相关危险因素分析[J]. 中国临床解剖学杂志, 2013, 31(4): 480-483.

GUO Wen-Chao, BO Su-Ti. The prevalence and related risk factors of hemorrhagic transformation in different subtype of cerebral infarction[J]. Chinese Journal Of Clinical Anatomy, 2013, 31(4): 480-483.

参考文献

[1] Terruso V, D'Amellio M, Di Benedetto N, et al. Frequency and determinants for hemorrhagic transformation of cerebral infarction
[J]. Neuroepidemiology, 2009, 33(3):261-265.

[2] Paciaroni M，Agnelli G，Corea F，et al． Early hemorrhagic transformation of brain infarction: rate，predictive factors，and influence on clinical outcome: results of a prospective multicenter study
[J]. Stroke, 2008, 39(8):2249-2256.

[3] Castellanos M, Sobrino T, Millán M, et al. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study
[J]. Stroke, 2007, 38(6):1855-1859.

[4] Aviv RI, dEsterre CD , Murphy BD , et al. Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion
[J].Radiology, 2009, 250(3):867-877.

[5] Akiyuki. Prediction of hemorrhagic transformation in ischemic stroke
[J]. Neuroepidemiology, 2009, 33(3):266-267.

[6] 盛文利, 黄如训.重视脑梗死的出血性转化
[J].中国神经精神疾病杂志, 2012, 38(2):126-128.

[7] Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
[J]. N Engl J Med, 1995, 333(24): 1581-1587.

[8] Thornhill RE, Chen S, Rammo W, et al. Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation
[J]. AJNR Am J Neuroradiol, 2010, 31(6):1015-1022.

[9] kerenyi L, Kardos L, Szasz J, et al. Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison
[J]. Eur J Neurol, 2006, 13(11): 1251-1255.

[10] Lin S, Wu B, Hao ZL, et al. Characteristics, treatment and outcomes of ischemic stroke with atrial fibrillation in a Chinese hospital based stroke study
[J]. Cerebrovasc Dis, 2011, 31(5):419-426.

[11]Kunte H, Busch MA, Trostdorf K, et al. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas
[J].Ann Neurol, 2012, 72(5):799-806.

[12]Paciaroni M, Agnelli G, Caso V, et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke
[J]. Cerebrovasc Dis, 2009, 28(2): 119-123.

[13]Ahmed N，Dávalos A，Eriksson N，et al． Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the safe implementation of treatments in stroke international stroke thrombolysis register (SITS-ISTR)
[J]. Arch Neurol，2010, 67(9):1123-1130.

[14]王伊龙, 王拥军, 吴敌. 等. 中国卒中防治研究现状
[J]. 中国卒中杂志, 2007, 2(1): 20-37.

[15]安中平,段建钢,王景华,等.不同类型卒中患者危险因素分布特征研究
[J]. 中国慢性病预防与控制,2010,18(4):380-382.